our mission
Revolutionize the clinical trial development process through cutting-edge AI. We empower life sciences stakeholders to make smarter, more confident decisions that reduce risk, improve trial success rates, and prioritize high-impact pipeline assets, ultimately accelerating the delivery of innovative therapies to patients while maximizing clinical and commercial value.
our customers
- Pharmaceutical industry
- Life sciences investment funds
- Contract research organizations (CRO)
Harness AI to smarter clinical drug development as well as smarter investments.
We strongly believe that the challenges of drug development delays, failures, and rising costs are not only rooted in clinical efficacy or safety issues, but also stem from a complex interplay of operational, strategic, regulatory, commercial, and financial risks.
Our platform is designed to address these multidimensional challenges holistically.
Join us on this bold journey to revolutionize drug development and pioneer a future where AI empowers unprecedented efficiency and innovation in clinical trials and portfolio management.
our approach
Unlocking the immense potential of data
One of the fundamental prerequisites for developing effective AI systems in the context of clinical trial prediction is access to abundant and high-quality data.
Our powerful approach is strategically built on Sorintellis’ proprietary large-scale multimodal database expertly curated, manually annotated, and rigorously validated by pharmaceutical experts in clinical trials, regulatory affairs, biostatistics, market access, pharmacology, drug safety, pricing strategy, portfolio management, and life sciences investment ensuring exceptional data quality and contextual relevance across the entire drug development lifecycle.
From Prediction to Actionable Insight: Sorintellis’ Explainable AI Approach
At Sorintellis, we believe that transforming clinical trial design requires more than just accurate predictions — it demands transparent, prescriptive, and interpretable insights.
Unlike traditional black-box models that offer little visibility into how conclusions are reached, our AI systems are designed to explain the “why” behind every prediction. By revealing the key risk drivers and their interactions, our models guide clinical teams on how to proactively reduce risk and optimize trial design.
This level of explainability is not optional — it’s essential. It enables cross-functional collaboration among scientists, regulatory experts, and decision-makers, and fosters trust in AI-assisted decision-making.
With Sorintellis, pharmaceutical teams embrace a data-driven, evidence-based approach that improves clinical outcomes and accelerates development timelines.
Causality-Driven Intelligence
At Sorintellis, we harness the power of causal inference to go beyond prediction and deliver actionable recommendations.
Our causal AI engine doesn’t just tell you what might happen — it reveals what would happen if you changed key parameters in your clinical trial design. By modeling cause-and-effect relationships, we simulate “what-if” scenarios to help sponsors understand the real impact of decisions.
With Sorintellis, teams gain actionable insights, not just forecasts — empowering them to optimize trial design, reduce risk, and accelerate development with confidence and clarity.